Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the clinical biomarkers market size evolved in recent years?

There has been impressive growth in the clinical biomarkers market size over the past few years. The market, which will expand from $30.78 billion in 2024 to $33.85 billion in 2025, is projected to record a compound annual growth rate (CAGR) of 10.0%. Factors motivating this growth during the historical period include an increased incidence of chronic illnesses, emphasis on personalized medication and targeted therapies, advancements in drug development and clinical studies, as well as regulatory backing and funding.

What are the predictions for the clinical biomarkers market size in the coming years?

In the coming years, the clinical biomarkers market is projected to experience a brisk expansion, ballooning to a size of $52.8 billion in 2029, with a compound annual growth rate (CAGR) of 11.8%. This anticipated growth within the forecasted time frame can be linked to the broadening scope of companion diagnostics, a more proactive approach towards early detection, and avoidance of diseases, along with increasing usage in precision oncology and neurodegenerative diseases, and a rise in infectious diseases. The forecast period will witness significant trends like AI-enabled biomarker discovery, incorporation of machine learning, multi-omics amalgamation, technological advancements, and strategic alliances among key market players.

Get your clinical biomarkers market report here!

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

What key factors are fueling the growth of the clinical biomarkers market?

The escalation of cancer incidence is anticipated to drive the clinical biomarker market’s expansion. Cancer refers to a variety of disorders characterized by the proliferation and uncontrolled division of abnormal cells, possessing the capacity to invade and damage healthy tissues. Clinical biomarkers carry essential importance in cancer prevention as they assist in early discovery, risk evaluation, and surveillance of individuals at elevated risk for developing cancer. For example, Cancer Research UK, a cancer-related research organization based in the UK, predicts a surge in new kidney cancer cases from about 16,300 to approximately 21,900 between 2023 and 2025, culminating to a 15% rise by 2038–2040. Hence, the upsurge in cancer incidence fuels the advancement of the clinical biomarker market.

How is the global clinical biomarkers market divided into key segments?

The clinical biomarkers market covered in this report is segmented –

1) By Offering: Product, Service

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies

3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas

4) By Application: Clinical Diagnostic, Translational Research

5) By End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users

Subsegments:

1) By Product: Diagnostic Kits, Reagents, Assay Kits, Instruments

2) By Service: Biomarker Discovery Services, Analytical Services, Clinical Trial Services, Data Analysis Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

Who are the key firms paving the way for growth in the clinical biomarkers market?

Major companies operating in the clinical biomarkers market include Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

Which trends are expected to transform the clinical biomarkers market?

The progression of technology is becoming a significant trend in the clinical biomarker industry. Leading firms in the market are inventing pioneering technologies to maintain their dominance. For example, in June 2023, Veravas Inc., a US-based medical product manufacturer with a focus on enhancing laboratory medicine, introduced VeraBIND technology. It offers a unique, advanced, and all-encompassing scope that increases the accuracy of biomarker identification while reducing the possibility of false positives or negatives in a variety of sample types. This innovation can enhance diagnostic procedures in clinical laboratories, enabling early detection of diseases and prompt, targeted interventions. Furthermore, VeraBIND sets a fast track for the development of assays, ensuring precision and uniformity in research, clinical studies, and diagnostic tests.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12670

What regions are contributing significantly to the growth of the clinical biomarkers market?

North America was the largest region in the clinical biomakers market in 2024. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Clinical Nutrition Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Clinical Decision Support Systems Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-decision-support-systems-global-market-report

Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: